These findings demonstrate that ALC effectively lowers plasma cholesterol and reduces hepatic lipid accumulation even in the absence of LDL receptors
Other information If you have vision problems, do not use your pen without help from a person trained to use the ZEPBOUND pen
As we continue to study the effects of GLP-1 medication, researchers are keen on understanding its impact on overall health and well-being beyond the initial weight loss period
In the study which was not peer reviewed the researchers examined a cohort of 413,557 patients who had been prescribed tirzepatide, liraglutide (Saxenda, Novo Nordisk), dulaglutide (Trulicity, Eli Lilly), injectable semaglutide (Wegovy, Novo Nordisk) or oral semaglutide (Rybelsus, Novo Nordisk) for a minimum of 180 days
This is the standard starting dose for GLP-1 therapy and is taken once weekly